deltatrials
Completed PHASE2 NCT00504192

A Phase II Study of Gemcitabine With Oxaliplatin as First Line Chemotherapy in Advanced Biliary Tract Cancer

A Phase II Study of Gemcitabine in Combination With Oxaliplatin as First Line Chemotherapy in Patients With Inoperable Biliary Tract Adenocarcinoma

Sponsor: Soonchunhyang University Hospital

Conditions Advanced Biliary Tract Adenocarcinoma Combination Chemotherapy Efficacy Gemcitabine Oxaliplatin
Interventions Gemcitabine and Oxaliplatin
Updated 6 times since 2017 Last updated: May 19, 2014 Started: Sep 30, 2006 Primary completion: Mar 31, 2008 Completion: Mar 31, 2009

This PHASE2 trial investigates Advanced Biliary Tract Adenocarcinoma and Combination Chemotherapy and is currently completed. Soonchunhyang University Hospital leads this study, which shows 6 recorded versions since 2006 — indicating limited longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.

Change History

6 versions recorded

  1. Sep 2025 — Present [monthly]

    Completed PHASE2

  2. Sep 2024 — Sep 2025 [monthly]

    Completed PHASE2

  3. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE2

  4. Jan 2021 — Jul 2024 [monthly]

    Completed PHASE2

  5. Jun 2018 — Jan 2021 [monthly]

    Completed PHASE2

▶ Show 1 earlier version

  1. Jan 2017 — Jun 2018 [monthly]

    Completed PHASE2

    First recorded

Sep 2006

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Soonchunhyang University Hospital
Data source: Soonchunhyang University Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

  • • Bucheon-si, South Korea